secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2023-06-01T23:59:59+00:00
Accession:  0000950170-23-025691
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics posts updated corporate presentation for investor meetings
-------------------------------------------------------------------------------

- Updated slide presentation posted on company website on June 1, 2023.
- No specific changes or material updates disclosed in the filing or attached exhibit.
- Presentation intended for use in meetings with investors and analysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017023025691/0000950170-23-025691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017023025691/lrmr-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-025691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer